Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-ABBS vs RIVAROXABAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITUXIMAB-ABBS vs RIVAROXABAN: Safety Overview

Metric RITUXIMAB-ABBS RIVAROXABAN
Total FAERS Reports 4,347 131,274
Deaths Reported 432 19,233
Death Rate 9.9% 14.7%
Hospitalizations 1,087 70,513
Average Patient Age 53.5 yrs 70.0 yrs
% Female Patients 74.2% 47.7%
FDA Approval Date N/A Apr 10, 2025
Manufacturer N/A Macleods Pharmaceuticals Limited
Route N/A ORAL
Marketing Status Prescription Prescription